Clay Shorrock
Chief Legal Officer and Executive Director, Business Development
@
Applied DNA Sciences
Clay Shorrock's Title
Clay Shorrock serves as the Chief Legal Officer and Executive Director of Business Development. In this dual role, he leverages his extensive legal background to guide the company's strategic initiatives and ensure compliance with complex regulatory frameworks. His expertise in intellectual property and business development makes him a pivotal figure in the organization's growth and legal fortitude.
Clay Shorrock's Education and Expertise
Clay Shorrock holds a B.A. in Biology from Franklin and Marshall College and a J.D. with a concentration in intellectual property from Seton Hall University Law School. His educational background forms a robust foundation for his specialization in intellectual property, patent law, and complex commercial transactions. With over a decade of experience, Shorrock is particularly noted for his work in biotechnology, molecular biology, immunotherapy, and medical diagnostics.
Clay Shorrock's Background
Clay Shorrock has built a distinguished career representing both Fortune 500 companies and development-stage enterprises. His legal acumen spans various aspects of intellectual property and patent law, particularly within the realms of biotechnology and medical diagnostics. Notably, Shorrock served as general and IP counsel to Applied DNA from 2016 through 2021, where he played a crucial role in guiding the company's legal strategy and intellectual property portfolio.
Clay Shorrock's Achievements
Throughout his career, Clay Shorrock has achieved significant milestones, particularly in the field of intellectual property law. His representation of high-profile clients, including Fortune 500 companies, underscores his capability in managing complex legal matters and transactions. During his tenure at Applied DNA, Shorrock's strategic legal insights and management of intellectual property significantly contributed to the company's innovation and compliance. His achievements in biotechnology, molecular biology, immunotherapy, and medical diagnostics have solidified his reputation as a leading expert in these sectors.